学院: 理工学院
性别:女
职称:副研究员
学历:研究生
学位:博士
学习经历:
2007.1-2010.12香港中文大学,医学院,博士
2003.9-2006.6暨南大学,药学院,硕士
1999.9-2003.6 广东药科大学,药学院,学士
工作经历:
2016-至今暨南大学食品安全与营养研究院,副研究员
2013 -2015暨南大学,生物学博士后流动站博士后
2011-2012香港中文大学,生物医学学院,研究助理。
研究方向:
食品营养干预和功能性食品
主持科研项目
1.国家自然科学基金青年科学基金项目:含硒藻胆蛋白拮抗人胰淀素诱导的胰岛β细胞凋亡的作用机理(21201082),2013/01-2015/12,25万。
2.中国博士后科学基金:TrxR靶向性的新型有机硒化合物的抗肿瘤作用机理,2012/05-2014/04,5万。
3.广东省自然科学基金博士启动项目:含硒藻胆蛋白拮抗人胰淀素诱导的胰岛
β细胞凋亡的作用机理(S2012040006919),2012/10-2014/09,3万。
4.暨南大学引进人才科研配套经费:有机硒对糖尿病引起肿瘤耐药的营养干预机制,201609/05-2019/09,20万。
5. 广东嘉应制药股份有限公司横向课题:抗肿瘤纳米药物的开发,2015/01-2018/12,40万。
代表性论文
1、Wen Liu#, Xiaoling Li # (共同第一作者), Yum-Shing Wong, Wenjie Zheng*, Yibo Zhang, Wenqiang Cao, Chen Tianfeng*. Selenium nanoparticles as a carrier of 5-Fluorouracil to achieve anticancer synergism. ACS Nano, 2012, 6 (8), 6578–6591.(IF=12.062,1区)
2、Xiaoling Li#, Lijuan Ma#, Wenjie Zheng, Tianfeng Chen*. Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis. Biomaterials, 2014, 35, 8596-8604. (IF=8.312,1区)
3、Li Y#, Li Xiaoling # (共同第一作者), Wong YS, Chen Tianfeng*, Zhang H, Liu C, Zheng W*. The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis. Biomaterials, 2011, 32, 9068-9076.(IF=8.312,1区)
4、Yifan Wang, Wenying Li, Yahui Yang, Qinsong Zeng, Ka-Hing Wong, Xiaoling Li* and Tianfeng Chen*. An integrin-targeting nanosystem as a carrier of the selenadiazole derivative to induce ROS-mediated apoptosis in bladder cancer cells, from rational design to action mechanisms. J. Mater. Chem. B, 2015, 3, 9374-9382.(IF=6.627,1区)
5、Yinghua Li, Xiaoling Li*, Wen-Jie Zheng, Cundong Fan, Yibo Zhang and Tianfeng Chen*. Functionalized selenium nanoparticles with nephroprotective activity, the important roles of ROS-mediated signaling pathways.J. Mater. Chem. B, 2013, 1 (46), 6365 – 6372. (Back cover).(IF=6.627,1区)
6、Wei Huang, Hualian Wu, Xiaoling Li*, Tianfeng Chen*. Facile one-pot synthesis of tellurium nanorods as antioxidant and anticancer agents. Chemistry-An Asian Journal, 2016, 11(16), 2218–2334.(IF=4.587)
7、Shulin Deng, Delong Zeng, Yi Luo, Jianfu Zhao, Xiaoling Li*, Zhennan Zhao, Tianfeng Chen*. Enhancement of Cell Uptake and Antitumor Activity of Selenadiazole Derivatives through Interaction and Delivery by Serum Albumin. RSC Advances. 2017, 7, 16721-16729.(IF=3.289)
8、Jianfu Zhao, Delong Zeng, Yuedan Liua, Yi Luo, Shengbin Ji, Xiaoling Li* and Tianfeng Chen*. Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways. Metallomics. 2017 Apr 4. doi: 10.1039/c7mt00001d. (IF=3.540)
9、Xiaoyan Fu, Yahui Yang, Xiaoling Li*, Haoqiang Lai, Yanyu Huang, Lizhen He, Wenjie Zheng, Chen Tianfeng*.RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway. Nanomedicine: Nanotechnology, Biology and Medicine, 2016, 12, 1627–1639. (IF=5.671)
10. Xiao-Ling Li, Tianfeng Chen, Yum-Shing Wong, Gang Xu*, Rong-Rong Fan,
Hai-Lu Zhao, Juliana C.N. Chan*. Involvement of mitochondrial dysfunction in
human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta
cells: an effect attenuated by phycocyanin. The International Journal of
Biochemistry & Cell Biology. 2011, 43, 525-534.(IF=4.634)
11. Li Xiaoling, Wong YS, Xu G, Chan JC*. Selenium-enriched Spirulina protects
INS-1E pancreatic beta cells from human islet amyloid polypeptide-induced
apoptosis through suppression of ROS-mediated mitochondrial dysfunction and
PI3/AKT pathway. Eur J Nutr. 2014 Aug 12. (IF=3.840)
12、Xiao-Ling Li, Gang Xu, Chen Tianfeng, Yum-Shing Wong, Hai-Lu Zhao, Rong-
Rong Fan, Xue-Mei Gu, Peter C.Y. Tong, Juliana C.N. Chan. Phycocyanin
Protects INS-1E pancreatic beta cells against human islet amyloid
polypeptide-induced apoptosis through attenuating oxidative stress and
modulating JNK and p38 mitogen-activated protein kinase pathways. The
International Journal of Biochemistry & Cell Biology. 2009, 41,
1526-1535.(IF=4.634)
13. Lijuan Ma#, Xiaoling Li# (共同第一作者),Yi Wang, Wenjie Zheng and
Tianfeng Chen*. Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced
beta cell apoptosis through induction of ROS-mediated mitochondrial
dysfunction. Journal of Inorganic Biochemistry, 2014, 140, 143–152.
(IF=3.197)
14. Qiang Xie#, Shenggui Liu#, Xiaoling Li# (共同第一作者), Qiong Wu, Zuandi
Luo, Xiaoyan Fu, Wenqiang Cao, Guoqiang Lan, Dan Li,* Wenjie Zheng,
Tianfeng Chen*. Dinuclear Zinc(II) Complexes Containing
(Benzimidazo1-2-yl)benzene That Overcome Drug Resistance in Hepatocellular
Carcinoma Cells through Induction of Mitochondria Fragmentation. Dalton
Transactions. 2014, 43 (19), 6973 – 6976.(IF=3.838)
15. Fang Yang, Ka-Hing Wong, Yufeng Yang, Xiaoling Li*, Jie Jiang, Wenjie
Zheng*, Hualian Wu, Tianfeng Chen. Purification and in vitro antioxidant
activities of tellurium-containing phycobiliproteins from tellurium-enriched
Spirulina platensis. Drug Design, Development and Therapy, 2014, 8,
1789-1800.(IF=3.026)
16. Yuedan Liu, Yi Luo, Xiaoling Li*, Wenjie Zheng, Tianfeng Chen*. Rational
design of selenadiazole derivatives to antagonize hyperglycemia-induced drug
resistance in cancer cells. Chemistry-An Asian Journal. 2015. 10, 3, 642–652.
(Back Cover). (IF=3.935)
17. Lijuan Ma, Yuanting Fu, Lianling Yu, Xiaoling Li*, Wenjie Zheng, Tianfeng
Chen*. Ruthenium complexes as inhibitors of human islet amyloid polypeptide
aggregation, an effect that prevents beta cell apoptosis. RSC Advances. 2015, 5,
17405-17412. (IF=3.708)
18. Yuan-Wei Liang,Junsheng Zheng,Xiaoling Li*,Wenjie Zheng, Tianfeng Chen*.
Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance
the radiosensitivity of cancer cells. European Journal of Medicinal Chemistry.
2015,84(30), pp 335-342. (IF=3.432)
19. Su, Jianyu*; Lai, Haoqiang; Chen, Jianping; Li, Lin; Wong, Yum-Shing; Chen,
Tianfeng; Li, Xiaoling*. Natural Borneol, a Monoterpenoid Compound,
Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular
Carcinoma Cells by Enhancement of Cellular Uptake and Activation of
ROS-Mediated DNA Damage. PLos One, 8(6), 2013/5/20. (IF=3.534)